Remove FDA Remove Information Remove Nutrition
article thumbnail

Citizen Journalism at its best – eFoodAlert and insights into “Abbott Nutrition: The Gathering Storm”

Bill Marler

Between September 1, 2019 and September 20, 2021, Abbott Nutrition received seventeen consumer complaints regarding multiple Similac powdered formula products. APPLIED – FOI II – BR Abbott Nutritions- FEI# 1815692 9-2021 EIR. The complaint was reviewed by an internal Abbott Nutrition Medical Team. FDA not blameless.

Nutrition 258
article thumbnail

Elevated Lead Levels in Cinnamon prompt FDA Warning and Recalls

Bill Marler

Through product testing, the FDA has determined that the ground cinnamon products listed in the table below contain elevated levels of lead and that prolonged exposure to these products may be unsafe. The FDA is advising consumers to throw away and not to buy these ground cinnamon products. What is the problem?

FDA 276
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Relaxes Nutrition Facts and Menu Labeling Requirements for Restaurants and Food Manufacturers During COVID-19 Emergency

Modern Restaurant Management

Food and Drug Administration (FDA) has issued two temporary food labeling guidance documents that attempt to balance industry supply and demand during the novel coronavirus pandemic. allergen information required by the Food Allergen Labeling and Consumer Protection Act.

Nutrition 164
article thumbnail

DeLauro Shares Whistleblower Report, Contaminated Infant Formula Led to Hospitalizations and Deaths

Bill Marler

House Appropriations Committee Chair Rosa DeLauro (D-CT-03) today submitted for the record a report acquired from a whistleblower who worked at the Abbott facility which produces infant formula recalled by the United States Food and Drug Administration (FDA) in February. Below are Chair DeLauro’s remarks.

FDA 315
article thumbnail

House and Senate Oversight on Cronobacter and Infant Formula this week

Bill Marler

Now the House and Senate are set to ask questions of the Industry and FDA about how the outbreak happened and how it impacted the supply of infant formula. Here is a preview of the FDA’s position See full testimony – FDA Testimony ECOI Infant Formula 5.25.2022 final : TESTIMONY OF. CALIFF, M.D. COMMISSIONER OF FOOD AND DRUGS.

Nutrition 300
article thumbnail

FDA: An Independent Review of FDA’s Foodborne Outbreak Response Processes

Bill Marler

There is an ongoing need for coordination of outbreak response within the FDA and with other federal and state agencies that touch on food safety.There is clearly an ongoing need to more effectively coordinated the multiple acronyms that make up governmental food safety responses at the federal, state, and local levels.

FDA 244
article thumbnail

FDA to allow Abbott to release product to individuals needing urgent, life-sustaining supplies of the specialty and metabolic formulas – with a Warning

Bill Marler

How confident should we feel with this waring from the FDA: “those seeking access [to the formula] should consult with their healthcare provider in considering whether the benefit of consuming such product outweighs the potential risk of bacterial infection in the user’s particular circumstances.”.

FDA 210